How Medicare Negotiated Drug Prices Compare to Other Countries

KFF December 19, 2024
Delaney Tevis, Matt McGough, Juliette Cubanski, Cynthia Cox

This analysis for the KFF-Peterson Health System Tracker compares the Medicare’s first-ever negotiated drug prices under a new process created by the Inflation Reduction Act of 2022 to current U.S. list prices, prices negotiated by the Department of Veterans Affairs (VA), and prices in 11 countries of similar size and wealth.

It finds that Medicare’s negotiated prices for 10 high-expenditure prescription drugs are lower...

Today's Sponsors

Today's Sponsor